---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-006279"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T05:08:22.932528+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne appoints Dr. Judith Klimovsky to board, expands to 11 directors

## Summary
- Dr. Klimovsky appointed independent director effective April 24, 2024; board temporarily expanded to 11 members (10 independent).
- She will serve on the Science & Technology Committee.
- Dr. Klimovsky is EVP & Chief Development Officer at Genmab; previously held senior roles at Novartis Oncology and Bristol-Myers Squibb.
- Board also approved a one-year waiver of mandatory retirement policy for Dr. Roeland Nusse.

## SEC filing metadata
- accession: 0001558370-24-006279
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837024006279/0001558370-24-006279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837024006279/tmb-20240424x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-006279
- JSON: https://secwatch.observer/filing/0001558370-24-006279.json
- Plain text: https://secwatch.observer/filing/0001558370-24-006279.txt

## Key facts
- Executive change
  Dr. Judith Klimovsky was appointed as Director at BIO-TECHNE Corp.
  - Action: appointed
  - Role: Director
  source text: On April 24, 2024, Bio-Techne Corporation (the “Company”) temporarily expanded the size of the Board of Directors from ten to eleven members and appointed Dr. Judith Klimovsky to the company's Board of Directors as an independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000155837024006279/0001558370-24-006279-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.